It has been reported that anti‐PD‐L1 therapy can induce remodeling of the macrophage compartment in responsive tumor models, primarily through increased levels of IFNγ, leading to a more proinflammatory phenotype and enhanced activity of CD8 T cells.21 This evidence concerns the gene CD8A and neoplasm.